Search by Drug Name or NDC
NDC 50419-0491-04 Climara Pro .045; .015 mg/d; mg/d Details
Climara Pro .045; .015 mg/d; mg/d
Climara Pro is a TRANSDERMAL PATCH in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayer HealthCare Pharmaceuticals Inc.. The primary component is ESTRADIOL; LEVONORGESTREL.
Product Information
| NDC | 50419-0491 |
|---|---|
| Product ID | 50419-491_f9c315d5-835d-4499-b4da-83dbd3dc696a |
| Associated GPIs | 24993002588820 |
| GCN Sequence Number | 053383 |
| GCN Sequence Number Description | estradiol/levonorgestrel PATCH TDWK 45-15/24H TRANSDERM |
| HIC3 | G1A |
| HIC3 Description | ESTROGENIC AGENTS |
| GCN | 20849 |
| HICL Sequence Number | 012871 |
| HICL Sequence Number Description | ESTRADIOL/LEVONORGESTREL |
| Brand/Generic | Brand |
| Proprietary Name | Climara Pro |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Estradiol and Levonorgestrel |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | PATCH |
| Route | TRANSDERMAL |
| Active Ingredient Strength | .045; .015 |
| Active Ingredient Units | mg/d; mg/d |
| Substance Name | ESTRADIOL; LEVONORGESTREL |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Pharmaceutical Class | Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021258 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50419-0491-04 (50419049104)
| NDC Package Code | 50419-491-04 |
|---|---|
| Billing NDC | 50419049104 |
| Package | 4 PATCH in 1 CARTON (50419-491-04) / 7 d in 1 PATCH |
| Marketing Start Date | 2013-11-21 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 59.8795 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | CLIMARA PRO PATCH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis